Found: 5
ОБЗОР2025 · pp. 64–74
Panyukov V.A., Zakharova V.A., Malinovskaya N.A., Shogenov Z.I., Nicheporenko Yu.A., Shikhmagomedova A.R.
Introduction. Purinergic signaling pathways in brain cells can play an important role both in physiological conditions and in depression and autism spectrum disorders. The purpose of this literature review was a systematic analysis of information in the modern…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42
Barinov E.F., Yureva A.S., Akhundova S.A., Giller D.I.
Aim of the study was to establish the significance of TR-receptor, P2X1-receptor and P2Y-receptor synergism for the efficiency of TC aggregation in patients with different sensitivity to non-selective NSAIDs, which will allow us to approach an understanding th…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 34–41
Barinov E.F., Malinin Y.Yu., Grigoryan H.V.
The study aims to analyze the dependence of an α1А-adrenoreceptor antagonist effectiveness on G-protein-coupled receptors (GPCRs) intracellular signaling in the passage of medium-sized calculi from the ureter. Material and methods. The study was prospective an…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 43–49
Barinov E.F., Grigoryan Kh.V., Malinin Y.Yu.
Аim of the study was to evaluate the activity of receptors that control contraction (α2-adrenergic receptor, purine P2X1 and P2Y receptors, angiotensin AT1 receptor, TxA2 receptor) and relaxation of smooth myocytes (adenosine A2 receptor) during standard litho…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 45–52
Barinov E.F., Malinin Y.Yu., Grigoryan Kh.V.
The reasons for the low efficiency of the α1A-blockers using in the scheme of lithokinetic therapy (LCT) remain unclear. The aim of the study was to evaluate the activity of the purinergic P2X1 receptor in the blockade of the α1A-adrenergic receptor during LCT…